Agilus Diagnostics launches comprehensive obesity & metabolic health test suite
The Vital Shape panels provide tiered assessments to detect obesity-related risks early
The Vital Shape panels provide tiered assessments to detect obesity-related risks early
Health Canada’s approval was based on a comprehensive evaluation of analytical, nonclinical, and clinical data
Sac-TMT is a novel human TROP2 ADC with proprietary intellectual property, targeting advanced solid tumors
Over 700 exhibitors from APAC, Europe, the US, and beyond showcased the latest in personal care innovation
The study met its primary endpoint, demonstrating a statistically significant and clinically meaningful improvement in invasive disease-free survival
Merus has licensed Halozyme’s proprietary ENHANZE technology to develop and commercialize subcutaneous formulations of petosemtamab
The new shadow roll-on delivers strong on-shelf presence with its modern rounded-base design
Nearly 1 in 3 HbA1c test results fall within the diabetic range, while 1 in 4 individuals show signs of prediabetes
FIBROSARC did not meet its primary PFS endpoint in the final analysi
The upcoming facility marks a strategic milestone in SOUKYA’s mission to make evidence-based holistic healthcare
Subscribe To Our Newsletter & Stay Updated